Legal & General Group
LEGN icon

Legal & General Group’s Legend Biotech LEGN Stock Holding History

Legal & General Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.58M Sell
227,867
-6,001
-3% -$162K ﹤0.01% 1429
2026
Q1 		$4.23M Buy
233,868
+6,918
+3% +$132K ﹤0.01% 1585
2025
Q4 		$4.93M Sell
226,950
-53,841
-19% -$1.54M ﹤0.01% 1560
2025
Q3 		$9.16M Sell
280,791
-6,248
-2% -$231K ﹤0.01% 1257
2025
Q2 		$10.2M Sell
287,039
-11,614
-4% -$376K ﹤0.01% 1176
2025
Q1 		$10.1M Sell
298,653
-1,122
-0.4% -$40.2K ﹤0.01% 1131
2024
Q4 		$9.75M Sell
299,775
-11,544
-4% -$478K ﹤0.01% 1193
2024
Q3 		$15.2M Buy
311,319
+9,122
+3% +$486K ﹤0.01% 955
2024
Q2 		$13.4M Sell
302,197
-5,138
-2% -$237K ﹤0.01% 979
2024
Q1 		$17.2M Buy
307,335
+669
+0.2% +$40.3K 0.01% 889
2023
Q4 		$18.5M Buy
306,666
+30,615
+11% +$1.94M 0.01% 867
2023
Q3 		$18.5M Sell
276,051
-2,473
-0.9% -$172K 0.01% 838
2023
Q2 		$19.2M Buy
278,524
+7,192
+3% +$470K 0.01% 854
2023
Q1 		$13.1M Buy
271,332
+47,021
+21% +$2.3M ﹤0.01% 949
2022
Q4 		$11.2M Buy
224,311
+9,252
+4% +$448K ﹤0.01% 1013
2022
Q3 		$8.77M Buy
215,059
+7,164
+3% +$336K ﹤0.01% 1093
2022
Q2 		$11.4M Buy
207,895
+27,312
+15% +$1.15M ﹤0.01% 1004
2022
Q1 		$6.56M Buy
180,583
+32,213
+22% +$1.27M ﹤0.01% 1373
2021
Q4 		$6.92M Buy
148,370
+145,891
+5,885% +$7.4M ﹤0.01% 1402
2021
Q3 		$125K Hold
2,479
– – ﹤0.01% 2801
2021
Q2 		$102K Sell
2,479
-815
-25% -$27.7K ﹤0.01% 2725
2021
Q1 		$96K Hold
3,294
– – ﹤0.01% 2636
2020
Q4 		$93K Buy
+3,294
New +$94.8K ﹤0.01% 2603

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Legal & General Group's LEGN Position: Q2 2026 in Review

Legal & General Group reduced its Legend Biotech (LEGN) stake by 2.6% in Q2 2026, selling an estimated $162K and leaving 227,867 shares worth $6.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1429.

Legal & General Group first reported a position in LEGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $19.2M in Q2 2023. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Legal & General Group held 227,867 shares of Legend Biotech worth $6.58M as of Q2 2026.
  • Legal & General Group sold 6,001 Legend Biotech shares in Q2 2026, an estimated $162K.
  • Legend Biotech made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1429 holding.
  • Legal & General Group first reported a position in Legend Biotech in Q4 2020 and has held it in 23 quarters since.
  • Legal & General Group's Legend Biotech position peaked at $19.2M in Q2 2023.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.